🇺🇸 FDA
Patent

US 9683009

Bone-selective osteogenic oxysterol-bone targeting agents

granted A61KA61K31/575A61K35/32

Quick answer

US patent 9683009 (Bone-selective osteogenic oxysterol-bone targeting agents) held by The Regents of the University of California expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/575, A61K35/32, A61P, A61P19/00